Log In
BCIQ
Print this Print this
 

C3

  Manage Alerts
Collapse Summary General Information
Company Alveonix AG
DescriptionTransient receptor potential cation channel subfamily M member 8 (TRPM8) agonist
Molecular Target Transient receptor potential cation channel subfamily M member 8 (TRPM8)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationDry eye
Indication DetailsTreat dry eye
Regulatory Designation
PartnerOra Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today